Expert Interview
Looking at the potential of long-acting amylin analogs for weight management, with a close look at the phase 1b data on Zealand Pharmaceuticals Petrelintide
Ticker(s): ZEAL, NVO, LLYInstitution: University of Pittsburgh Medical Center
- Clinical Associate Professor of Medicine & Endocrinologist at UPMC
- Diabetes Clinical Unit Leader who sees 200+ patients with Type 1 Diabetes
- Clinical and Research Interest in diabetes technology and multidisciplinary modes of care
Roughly how many patients with obesity do you manage?
Added By: ben_adminOn a scale from 1-10 (10 being extremely excited) how would you rate your level of excitement for Petrelintide?
Added By: ben_adminWhat is your high level view on the potential of long-acting amylin analogs for weight management?
Added By: ben_adminAre you convinced that long-acting amylin analogs are more efficaious and/or safer than GLP-1 medications?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
